Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.
Breast Cancer Res Treat. 2018 Jan;167(1):39-47. doi: 10.1007/s10549-017-4502-3. Epub 2017 Sep 13. Breast Cancer Res Treat. 2018. PMID: 28905250